Petros Pharmaceuticals, Inc. PTPI
0.00
(0.01)
(100.00%)
as of 25 Sep
- Market cap
- $1.0M
- P/E
- 0.0×
Follow PTPI
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
2.20 | 2.24 | 1.66 | 1.23 | |
Current Ratio |
2.22 | 2.25 | 1.68 | 1.25 | |
Net Debt/EBITDA |
6.13 | 13.12 | 4.24 | 3.53 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.98 | 0.54 | 0.79 | 0.06 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | — | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.03) | (0.03) | (0.02) | (0.02) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.03) | (0.03) | (0.02) | (0.02) | |
Cash per Share |
0.14 | 0.18 | 0.09 | 0.07 | |
Shareholders Equity per Share |
0.08 | 0.10 | 0.04 | 0.01 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.08 | 0.10 | 0.04 | 0.01 | |
Free Cash Flow |
(1.13) | (0.93) | (0.78) | (0.86) | |
Working Capital |
3.37 | 2.87 | 1.77 | 0.70 | |
Net Current Asset Value |
3.37 | 2.87 | 1.77 | 0.70 | |
EV/EBIT |
— | — | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
1.01 | 0.42 | 0.45 | 0.53 | |
Average Assets |
13.41 | 7.90 | 11.00 | 5.47 | |
Average Common Equity |
3.24 | (2.30) | (3.91) | 2.57 |
Columns are period end dates